Found 10 results

Name Type of Offering Accepted Date
Oncternal Therapeutics, Inc. See All Filings
D 2016-06-08 14:36:33
Amount To Be Raised $13,135,714
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-16-069073
Exclusions or Exemptions 506b
Accepted Date 2016-06-08 14:36:33
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Oncternal Therapeutics, Inc. See All Filings
D 2018-11-20 18:50:25
Amount To Be Raised $24,000,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001567619-18-006807
Exclusions or Exemptions 506b
Accepted Date 2018-11-20 18:50:25
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
TOKALAS, INC. See All Filings
D 2015-08-07
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-15-030436
Exclusions or Exemptions 506b
Accepted Date 2015-08-07
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Oncternal Therapeutics, Inc. See All Filings
D 2016-07-08 11:28:46
Amount To Be Raised $3,300,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-16-071979
Exclusions or Exemptions 506b
Accepted Date 2016-07-08 11:28:46
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
Oncternal Therapeutics, Inc. See All Filings
D/A 2016-10-19 18:45:07
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-16-083095
Exclusions or Exemptions 506b
Accepted Date 2016-10-19 18:45:07
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Oncternal Therapeutics, Inc. See All Filings
D/A 2016-12-08 19:09:07
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-16-089151
Exclusions or Exemptions 506b
Accepted Date 2016-12-08 19:09:07
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Oncternal Therapeutics, Inc. See All Filings
D 2017-09-27 16:27:27
Amount To Be Raised $11,251,125
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-17-036629
Exclusions or Exemptions 506b
Accepted Date 2017-09-27 16:27:27
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
TOKALAS, INC. See All Filings
D 2014-03-03
Amount To Be Raised $3,280,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-14-011051
Exclusions or Exemptions 506b
Accepted Date 2014-03-03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
TOKALAS, INC. See All Filings
D/A 2016-03-10
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-16-057332
Exclusions or Exemptions 506b
Accepted Date 2016-03-10
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Oncternal Therapeutics, Inc. See All Filings
D/A 2017-03-23 16:36:30
Amount To Be Raised $23,504,838
Associated Brokers / Dealers N/A
CIK Number 0001600987
Filed Document 0001140361-17-013027
Exclusions or Exemptions 506b
Accepted Date 2017-03-23 16:36:30
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity